Ethismos Research, Inc. is a clinical stage pharmaceutical/drug development company based in Cambridge, Massachusetts. Our team develops medications for Substance Use Disorders (SUD) to achieve a change in habits and to empower and support those returning to a life free of substance use.
The Ethismos R&D pipeline is focused on therapies for SUDs including:
Risk reduction for Opioid Use Disorder in chronic pain (as adjunct to prescribed opioids for chronic pain)
In addition to clinical development programs in SUD, Ethismos has ongoing research programs focused on the underlying mechanisms of other serious disorders including Treatment Resistant Depression.
We are dedicated to discovering and developing safe and effective therapies for addiction, depression and chronic pain that will have a positive impact on the lives of patients, their families and loved ones, and their communities.
We welcome you to explore our website and learn more about our research, medicines, R&D pipeline, team and related resources.